Email this page: News Release

Analysis of Data from Two Phase 3 Studies Shows DIFICID® Offered Faster Diarrheal Symptom Improvement than Oral Vancomycin in Patients with Cancer Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)

To (email address):   Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your email address:   Copy yourself These email addresses will be used to email the page on your behalf and will not be used by Optimer Pharmaceuticals, Inc. for any marketing purposes.
Add a comment:
Send:    Full page    Link to page
Type in number:
This helps Optimer Pharmaceuticals, Inc. prevent automated submissions.